Polaroid Therapeutics (PTx), founded in 2022, is a healthcare company focused on developing innovative antimicrobial solutions for wound healing and additional indications with unmet medical needs. As a spinoff of Polaroid, our mission is to bring to life the best of Polaroid's vision of creating a more human and meaningful world through cutting-edge technology and research. Our proprietary technology is designed to address major challenges in antimicrobial therapies and improve patient outcomes. We are committed to positively impacting the lives of patients and their families by delivering superior treatments that prevent, heal, and improve the quality of life. We aspire to reach and help all humankind around the globe.